Yamashita et al. (2018) researched 149 EC patients, finding in the MSI+ EC group that expressions of CD8 and PD-1 on the surface of infiltrating lymphocytes and PD-L1 on the surface of tumour cells were significantly higher than in MSS EC. Here, CD274 is linked to neoplasm.